Hong Kong residents who had already received their first shot of the BioNTech vaccine reacted with shock and alarm on Wednesday morning when the government suspended the use of the jab after reports of packaging defects, but many felt they were still in the dark on what to expect next.Of the 585,000 doses in the first batch dispensed, or batch 210102, about a quarter, or 150,000, had been used so far. In Hong Kong, Fosun Pharma is in charge of delivering the jab jointly developed by Germany’s…
READ SOURCE